News & Updates
Filter by Specialty:
Will a bedtime snack help treat hyperglycaemia in type 2 diabetes?
There is no convincing benefit to consuming a bedtime snack for glycaemic control in individuals with type 2 diabetes (T2D) or prediabetes, according to the results of a systematic review.
Will a bedtime snack help treat hyperglycaemia in type 2 diabetes?
02 Dec 2022
Maximum home BP predicts cardiovascular outcomes in T2D patients
In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.
Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
Utility of pituitary transcription factors (TFs) improves the diagnostic accuracy and prognostication of nonfunctioning pituitary neuroendocrine tumours (NF-PitNETs), according to local data and a new diagnostic classification presented at the 5th Annual Meeting of Endocrinology, Diabetes & Metabolism Hong Kong (EDM HK).
Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
30 Nov 2022
Low-carb vegan diet reduces weight, greenhouse gas emissions
Vegan and vegetarian diets that are low in carbohydrates reduce body weight as well as improve glycaemic control and blood pressure in individuals with type 2 diabetes (T2D), suggests a study, adding that a plant-based diet shows greater potential decrease in greenhouse gas emissions.
Low-carb vegan diet reduces weight, greenhouse gas emissions
23 Nov 2022
GLP-1 receptor agonists halt COPD exacerbations in T2D patients
Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps prevent severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes (T2D), a UK study has shown.
